AAAAAA

   
Results: 1-17 |
Results: 17
Selective urological evaluation in men with febrile urinary tract infection
Authors: Ulleryd, P Zackrisson, B Aus, G Bergdahl, S Hugosson, J Sandberg, T
Citation: P. Ulleryd et al., Selective urological evaluation in men with febrile urinary tract infection, BJU INT, 88(1), 2001, pp. 15-20
Bone marrow micrometastases in patients with stage I-II localised prostatecancer
Authors: Vagunda, V Landys, K Kankkunen, JP Vagundova, M Hultborn, R Kovarik, J Hugosson, J
Citation: V. Vagunda et al., Bone marrow micrometastases in patients with stage I-II localised prostatecancer, EUR J CANC, 37(15), 2001, pp. 1847-1852
Outcome of laterally directed sextant biopsies of the prostate in screenedmales aged 50-66 years - Implications for sampling order
Authors: Aus, G Bergdahl, S Hugosson, J Lodding, P Pihl, CG Pileblad, E
Citation: G. Aus et al., Outcome of laterally directed sextant biopsies of the prostate in screenedmales aged 50-66 years - Implications for sampling order, EUR UROL, 39(6), 2001, pp. 655-660
Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers
Authors: Hugosson, J Lilja, H Lodding, P Pihl, CG
Citation: J. Hugosson et al., Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers, EUR UROL, 39, 2001, pp. 33-34
Inguinal hernia after radical retropubic prostatectomy for prostate cancer: A study of incidence and risk factors in comparison to no operation and lymphadenectomy
Authors: Lodding, P Bergdahl, C Nyberg, M Pileblad, E Stranne, J Hugosson, J
Citation: P. Lodding et al., Inguinal hernia after radical retropubic prostatectomy for prostate cancer: A study of incidence and risk factors in comparison to no operation and lymphadenectomy, J UROL, 166(3), 2001, pp. 964-967
Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys(145)-Lys(146)
Authors: Nurmikko, P Pettersson, K Piironen, T Hugosson, J Lilja, H
Citation: P. Nurmikko et al., Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys(145)-Lys(146), CLIN CHEM, 47(8), 2001, pp. 1415-1423
Would prostate cancer detected by screening with prostate-specific antigendevelop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden
Authors: Hugosson, J Aus, G Becker, C Carlsson, S Eriksson, H Lilja, H Lodding, P Tibblin, G
Citation: J. Hugosson et al., Would prostate cancer detected by screening with prostate-specific antigendevelop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden, BJU INT, 85(9), 2000, pp. 1078-1084
Screening and early detection of prostate cancer
Authors: Schroder, FH Alexander, FE Bangma, CH Hugosson, J Smith, DS
Citation: Fh. Schroder et al., Screening and early detection of prostate cancer, PROSTATE, 44(3), 2000, pp. 255-263
Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment
Authors: Ahlgren, G Pedersen, K Lundberg, S Aus, G Hugosson, J Abrahamsson, PA
Citation: G. Ahlgren et al., Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment, PROSTATE, 42(4), 2000, pp. 274-279
Neuroendocrine differentiation is not prognostic of failure after radical prostatectomy but correlates with tumor volume
Authors: Ahlgren, G Pedersen, K Lundberg, S Aus, G Hugosson, J Abrahamsson, PA
Citation: G. Ahlgren et al., Neuroendocrine differentiation is not prognostic of failure after radical prostatectomy but correlates with tumor volume, UROLOGY, 56(6), 2000, pp. 1011-1015
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
Authors: Becker, C Piironen, T Pettersson, K Hugosson, J Lilja, H
Citation: C. Becker et al., Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater, UROLOGY, 55(5), 2000, pp. 694-699
Transrectal ultrasound anatomy of the prostate and seminal vesicles in healthy men
Authors: Zackrisson, B Hugosson, J Aus, G
Citation: B. Zackrisson et al., Transrectal ultrasound anatomy of the prostate and seminal vesicles in healthy men, SC J UROL N, 34(3), 2000, pp. 175-180
Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography
Authors: Ulleryd, P Zackrisson, B Aus, G Bergdahl, S Hugosson, J Sandberg, T
Citation: P. Ulleryd et al., Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography, BJU INT, 84(4), 1999, pp. 470-474
Rationale for randomised trials of prostate cancer screening
Authors: Alexander, FE Andriole, GL Aus, G Auvinen, A Beensterboer, P Blijenberg, BG Bonardi, R Buys, S Candas, B Ciatto, S Crawford, ED Demers, R de Koning, HJ Denis, L Dijk, MA Figueiredo, F Gellman, EP Gohagan, J Hakama, M Hugosson, J Kirkels, WI Kranse, R van der Kwast, TH Lilja, H Maattanen, L Mandel, J Miller, AB Monteiro, H Nelen, V Oberman, A Paez, A Prorok, PC Reding, D Rietbergen, JWBW Rose, DB Sanchez, AB Schroder, FH da Silva, EC Simpson, N Smith, PH Stadaert, B Stenman, UH Teppo, L Turkes, A Weissfeld, JL Yokochi, L
Citation: Fe. Alexander et al., Rationale for randomised trials of prostate cancer screening, EUR J CANC, 35(2), 1999, pp. 262-271
Predictors for biopsy outcome in the European randomized study of screening for prostate cancer (Rotterdam region)
Authors: Kranse, R Beemsterboer, P Rietbergen, J Habbema, D Hugosson, J Schroder, FH
Citation: R. Kranse et al., Predictors for biopsy outcome in the European randomized study of screening for prostate cancer (Rotterdam region), PROSTATE, 39(4), 1999, pp. 316-322
Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy
Authors: Ahlgren, G Pedersen, K Lundberg, S Aus, G Hugosson, J Abrahamsson, PA
Citation: G. Ahlgren et al., Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy, UROLOGY, 54(2), 1999, pp. 329-334
Transrectal ultrasound with separate measurement of the transition zone volume predicts the short-term outcome after transurethral resection of the prostate
Authors: Bergdahl, S Aus, G Lodding, P Norlen, L Hugosson, J
Citation: S. Bergdahl et al., Transrectal ultrasound with separate measurement of the transition zone volume predicts the short-term outcome after transurethral resection of the prostate, UROLOGY, 53(5), 1999, pp. 926-930
Risultati: 1-17 |